Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Agenus, Arch, Arcturus, Celltrion, Daewoong, Eisai, Humanigen, Immunitybio, Inmune, Israel Institute for Biological Research, Neurorx, Novartis, Pfizer, Relief, Sheba Medical Center.